Lead Product(s): VAX-001
Therapeutic Area: Infections and Infectious Diseases Product Name: VAX-001
Highest Development Status: Preclinical Product Type: Vaccine
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 16, 2021
Covigenix VAX-001 encodes the SARS-CoV-2 Spike protein and uses novel Fusogenix technology for delivery. Using a NG-gene delivery technology to existing and approved mRNA vaccines, the VAX-001 DNA vaccine delivers the information needed inside cells to make the viral protein.